Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy
Background: Valproic acid (VPA) is a mainstay of treatment for epilepsy. Although VPA is generally considered well tolerated, it has serious adverse effects related to the pathological impact on cerebral perfusion and oxidative metabolism, leading to progressive encephalopathy. Erythrocytes directly...
Saved in:
| Main Authors: | Lyudmila Tikhonova, Eugene Maevsky, Carmina Montoliu, Elena Kosenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/4/588 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Valproate-induced Hyperammonemic Encephalopathy
by: Hsiao-Feng Chou, et al.
Published: (2008-10-01) -
Efficacy of olanzapine combined with magnesium valproate sustained release tablets in the treatment of mental disorders caused by uremic encephalopathy
by: LUO Jun-hui, et al.
Published: (2019-01-01) -
Encephalopathy with Hashimoto’s Thyroiditis
by: J Gordon Millichap
Published: (2003-10-01) -
Cognitive Effects of Topiramate and Valproate
by: J Gordon Millichap
Published: (2003-06-01) -
Valproate Metabolites and Hyperammonemia
by: J Gordon Millichap
Published: (1992-07-01)